Showing results (41-50 of 69) with videos related to
Sort By:
Pageof 7
Lancet (London, England)|February 4, 1989
Localisation of endocrine-related tumours with radioiodinated analogue of somatostatinE P Krenning, W H Bakker, W A Breeman, et al.International Journal of Cancer|September 20, 2000
Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapyP M van Hagen, W A Breeman, H F Bernard, et al.Anticancer Research|May 6, 1998
Tissue distribution and metabolism of radioiodinated DTPA0, D-Tyr1 and Tyr3 derivatives of octreotide in ratsW A Breeman, M de Jong, B Bernard, et al.EJNMMI Research|November 23, 2016
Improved safety and efficacy of <sup>213</sup>Bi-DOTATATE-targeted alpha therapy of somatostatin receptor-expressing neuroendocrine tumors in mice pre-treated with L-lysineHo Sze Chan, Mark W Konijnenberg, Tamara Daniels, et al.Italian Journal of Gastroenterology and Hepatology|December 22, 1999
Scintigraphy and radionuclide therapy with [indium-111-labelled-diethyl triamine penta-acetic acid-D-Phe1]-octreotideE P Krenning, R Valkema, P P Kooij, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1995
Effect of dose and specific activity on tissue distribution of indium-111-pentetreotide in ratsW A Breeman, D J Kwekkeboom, P P Kooij, et al.International Journal of Cancer|October 16, 1999
Pre-clinical evaluation of [(111)In-DTPA-Pro(1), Tyr(4)]bombesin, a new radioligand for bombesin-receptor scintigraphyW A Breeman, M De Jong, B F Bernard, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 1, 1992
Evaluation of the incremental diagnostic value and impact on patient treatment of thallium scintigraphyW P Oosterhuis, M G Niemeyer, A F Kuijper, et al.Nuclear Medicine Communications|February 1, 1993
Exercise 201Tl scintigraphy: evaluation of the additional diagnostic valueW P Oosterhuis, M G Niemeyer, A Breeman, et al.International Journal of Cancer|May 8, 2001
[177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapyM de Jong, W A Breeman, B F Bernard, et al.Pageof 7